A. İhsan Ertenli

Akademik Derece: İç Hastalıkları ve Romatoloji Uzmanı

Romatoloji Profösörü

1. Sociodemographic and Clinical Determinants of Colchicine Adherence in Adults with Familial Mediterranean Fever: A Cross-Sectional StudyBÖLEK E. Ç., BİLGİN E., KARDAŞ R. C., KILIÇ L., KİRAZ S., ERTENLİ A. İ., et al.Rheumatology and Therapy, cilt.13, sa.5, ss.1357-1377, 2026 (SCI-Expanded, Scopus)
2. Efficacy and safety of leflunomide with tumor necrosis factor inhibitors in psoriatic arthritis: a retrospective analysisÇAKIR İ. Y., BİLGİN E., FIRLATAN YAZGAN B., EKİCİ M., Bayram G. S. K., ÜNALDI E., et al.Clinical Rheumatology, cilt.45, sa.9, ss.5553-5562, 2026 (SCI-Expanded, Scopus)
3. Treatment response and retention rates of bDMARDs in advanced spinal ankylosis or bamboo spine: Real-world data from the HUR-BIO registry İleri spinal ankiloz veya bambu omurga olan hastalarda bDMARD tedavi yanıtı ve ilaç devamlılığı: HUR-BIO kayıt sisteminden gerçek yaşam verileriFarisoğulları B., Machado P., YARDIMCI G. K., BİLGİN E., BÖLEK E. Ç., SARIYILDIZ E., et al.Journal of Turkish Society For Rheumatology, cilt.18, sa.2, ss.195-203, 2026 (Scopus, TRDizin)
4. Recommendations of the Turkish Society for Rheumatology on tuberculosis screening and treatment in patients receiving advanced antirheumatic drug therapy Gelişmiş antiromatizmal ilaç tedavisi alacak hastalarda tüberküloz taraması ve tedavisi için Türkiye Romatoloji Derneği önerileriBes C., Deniz R., EKİCİ M., İlgen U., İnce B., Özsoy Z., et al.Journal of Turkish Society For Rheumatology, cilt.18, sa.2, ss.140-149, 2026 (Scopus, TRDizin)
5. Baseline body mass index and early functional recovery after first recorded advanced therapy in rheumatoid arthritis: a real-world cohort studyTatar O. D., KILIÇ L., KALYONCU U., ERTENLİ A. İ.Rheumatology International, cilt.46, sa.6, 2026 (SCI-Expanded, Scopus)
6. Efficacy, retention, and safety of baricitinib in real-life: HUR-BIO monocentric experience Baricitinibin gerçek hayattaki etkinliği, kalıcılığı ve güvenliği: HÜR-BİO tek merkezli deneyimiEKİCİ M., İçli İ. Y., Deregözü E. E., BİLGİN E., ÖZSOY Z., AYAN G., et al.Journal of Turkish Society For Rheumatology, cilt.18, sa.1, ss.108-118, 2026 (Scopus, TRDizin)
7. Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registryAta E. B., KILIÇ L., Fırlatan Yazgan B., Kart Bayram S. G., Ekici M., Ünaldı E., et al.Clinical Rheumatology, cilt.45, sa.2, ss.781-789, 2026 (SCI-Expanded, Scopus)
8. Exaggerated axial osteoproliferation in patients with spondyloarthritis accompanying chronic kidney diseaseUzun G. S., APAYDIN ROLLAS A. E., HABERAL G., YETER H. H., AYAN G., ERDEM Y., et al.Clinical Rheumatology, 2026 (SCI-Expanded, Scopus)
9. Relapse in adult idiopathic inflammatory myopathies: clinical predictors and the potential role of anti-NXP2 in a single-center retrospective cohort studyEKİCİ M., İçli İ. Y., YARDIMCI G. K., ÖZSOY Z., ÜNALDI E., Fırlatan B., et al.Clinical Rheumatology, 2026 (SCI-Expanded, Scopus)
10. Türkiye Romatoloji Derneği - Romatoloji ve Malignite Çalışma Grubu enflamatuvar artrit ve malignite: Sistematik derlemeye dayalı risk değerlendirmesi ve klinik yönetim üzerine fikir birliği raporuBabaoglu H., TEKGÖZ E., Dağlı P. A., Vasi İ., Ulusoy B. Ö., Gokten D. B., et al.Ulusal Romatoloji Dergisi, cilt.17, sa.3, ss.145-154, 2025 (Scopus, TRDizin)
11. Real-World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney DiseaseGokten D. B., Tezcan M. E., YAĞIZ B., ERDEN A., KİMYON G., YAŞAR BİLGE N. Ş., et al.INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.28, sa.5, 2025 (SCI-Expanded, Scopus)
12. Biyolojik DMARD kullanan veya başlanacak olan seropozitif ve seronegatif romatoid artrit hastalarının karşılaştırılmasıozsoy z., DAGLIOGLU S. A. G., Ayan G., uzun g. s., EKİCİ M., Ünaldı E., et al.Ulusal Romatoloji Dergisi, cilt.17, sa.1, ss.53-59, 2025 (Scopus, TRDizin)
13. ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritisUzun G. S., SARIKAYA Y., Arslan S., EKİCİ M., ATA E. B., KARCIOĞLU O., et al.CLINICAL RHEUMATOLOGY, cilt.44, sa.3, ss.1031-1040, 2025 (SCI-Expanded, Scopus)
14. Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality ratesSandal Uzun G., Taghiyeva A., Çakır İ. Y., Moral K., YARDIMCI G. K., Bölek E. Ç., et al.International Journal of Rheumatic Diseases, cilt.27, sa.1, 2024 (SCI-Expanded, Scopus)
15. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO RegistryDuran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.Rheumatology and Therapy, cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded, Scopus)
16. Comparison of lupus nephritis and non-lupus nephritides in patients with systemic lupus erythematosusDURAN E., BİLGİN E., KALYONCU U., ERTENLİ A. İ., YILDIRIM T., ARICI M., et al.Ulusal Romatoloji Dergisi, cilt.15, sa.1, ss.18-24, 2023 (Scopus, TRDizin)
17. Association between oxygen delivery and digital ulcers in systemic sclerosisAKDOĞAN A., Sari A., Sener Y. Z., Oksul M., Armagan B., KILIÇ L., et al.Microvascular Research, cilt.145, 2023 (SCI-Expanded, Scopus)
18. Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approachARMAĞAN B., OKŞUL M., ŞENER Y. Z., SARI A., ERDEN A., YARDIMCI G. K., et al.Turkish Journal of Medical Sciences, cilt.53, sa.2, ss.563-571, 2023 (SCI-Expanded, Scopus, TRDizin)
19. Recurrent Aphthous Stomatitis and Related Factors in Turkish Adult Population: A Striking Outcome of Cappadocia Chronic Diseases Epidemiological StudyÇALIK BAŞARAN N., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., ERDEN A., KILIÇ L., et al.Cumhuriyet Tıp Dergisi (ELEKTRONİK), cilt.44, sa.3, ss.233-238, 2022 (Hakemli Dergi)
20. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experienceSARIYILDIZ E., YILDIRIM T., Taghiyeva A., Bilgin E., ARICI M., Saglam E. A., et al.LUPUS, cilt.31, ss.1147-1156, 2022 (SCI-Expanded, Scopus)
21. Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry resultsAYAN G., Farisogullari B., BİLGİN E., BÖLEK E. Ç., KubraYardimci G., DURAN E., et al.CLINICAL RHEUMATOLOGY, cilt.41, sa.5, ss.1439-1446, 2022 (SCI-Expanded, Scopus)
22. Evaluating skeletal muscle mass with ultrasound in patients with systemic sclerosisSARI A., EŞME M., ŞENGÜL AYÇİÇEK G., ARMAĞAN B., KILIÇ L., ERTENLİ A. İ., et al.NUTRITION, cilt.84, 2021 (SCI-Expanded, Scopus)
23. Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: "Inflammatory Thrombosis with Immune Endotheliitis-ITIE"BİLGİN E., ERTENLİ A. İ.RHEUMATOLOGY INTERNATIONAL, cilt.41, sa.3, ss.679-680, 2021 (SCI-Expanded, Scopus)
24. How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?SARI A., ŞENER Y. Z., ARMAĞAN B., KILIÇ L., KAYA E. B., HEKİMSOY V., et al.ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.25, sa.1, ss.30-35, 2021 (SCI-Expanded, Scopus, TRDizin)
25. Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemicKALYONCU U., PEHLİVAN Y., AKAR S., KAŞİFOĞLU T., Kimyon G., KARADAĞ Ö., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.4, ss.1615-1623, 2021 (SCI-Expanded, Scopus, TRDizin)
26. Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experienceBİLGİN E., Ceylan F., DURAN E., Farisogullari B., BÖLEK E. Ç., YARDIMCI G. K., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.1, ss.297-308, 2021 (SCI-Expanded, Scopus, TRDizin)
27. The frequency of Achilles and plantar calcaneal spurs in gout patientsDURAN E., BİLGİN E., ERTENLİ A. İ., KALYONCU U.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.4, ss.1841-1848, 2021 (SCI-Expanded, Scopus, TRDizin)
28. Pregnancy outcomes in partners of male ankylosing spondylitis patients treated with anti-tumour necrosis factor-alpha biologics: real-life results from a single-centre cross-sectional studyUYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.RHEUMATOLOGY INTERNATIONAL, cilt.40, sa.9, ss.1501-1507, 2020 (SCI-Expanded, Scopus)
29. Periaortitis and Coronary Arteritis in IgG4-Related Disease: Eastern Mediterranean ExperienceYARDIMCI G. K., SARI A., Erden A., BÖLEK E. Ç., Farisogullari B., KILIÇ L., et al.ARTHRITIS & RHEUMATOLOGY, cilt.71, 2019 (SCI-Expanded, Scopus)
30. Retention Rates and Response of Anti-TNF Treatments in the Enteropathic Spondylitis: HUR-BIO Real Life ResultsYARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.ARTHRITIS & RHEUMATOLOGY, cilt.71, 2019 (SCI-Expanded, Scopus)
31. Target Organ Associations in Polyarteritis Nodosa (PAN): Results of a Worldwide Collaboration StudyKARADAĞ Ö., Furuta S., Hocevar A., Gazel U., Hinojosa-Azaola A., UĞURLU S., et al.ARTHRITIS & RHEUMATOLOGY, cilt.71, 2019 (SCI-Expanded, Scopus)
32. Tuberculin Skin Test and Quantiferon (R)-TB Gold In-Tube Test for Latent Tuberculosis Before Biologic Treatments: Lower Agreement Rate in Spondyloarthropathies Compared to Rheumatoid ArthritisIlgen U., Turan S., EMMUNGİL H., SARI A., ERDEN A., KILIÇ L., et al.ARTHRITIS & RHEUMATOLOGY, cilt.71, 2019 (SCI-Expanded, Scopus)
33. Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life ResultsFarisogullari B., YARDIMCI G. K., SARI A., ARMAĞAN B., BİLGİN E., BÖLEK E. Ç., et al.ARTHRITIS & RHEUMATOLOGY, cilt.71, 2019 (SCI-Expanded, Scopus)
34. Mortality Ratio and Risk Factors in CT Confirmed Rheumatoid Arthritis Related Lung Disease: UIP, Pleural Effusion and the Time of Diagnosis of Rheumatoid Arthritis - Lung DiseaseEKİCİ M., SARI A., BAYTAR Y., BÖLEK E. Ç., ARMAĞAN B., BİLGİN E., et al.ARTHRITIS & RHEUMATOLOGY, cilt.71, 2019 (SCI-Expanded, Scopus)
35. Methodology of a new inflammatory arthritis registry: TReasureKALYONCU U., Tascilar E. K., ERTENLİ A. İ., DALKILIÇ H. E., Bes C., Kucuksahin O., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.48, sa.4, ss.856-861, 2018 (SCI-Expanded, Scopus, TRDizin)
36. SKLERODERMA, SİSTEMİK LUPUS ERİTEMATOZUS VE FİBROMİYALJİ TANILI HASTALARIN HASTALIK HAKKINDAKİ BİLGİ DÜZEYLERİNİN İNCELENMESİARIN G., KARACA N. B., OFLAZ F. B., AKDOĞAN A., APRAŞ BİLGEN Ş. Ş., ERTENLİ A. İ., et al.Journal of Exercise Therapy and Rehabilitation, cilt.4, sa.3, 2017 (Hakemli Dergi)
37. Comparing polyarteritis nodosa in children and adults: a single center studyERDEN A., BATU AKAL E. D., SÖNMEZ H. E., SARI A., ARMAĞAN B., ARICI Z. S., et al.INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.20, sa.8, ss.1016-1022, 2017 (SCI-Expanded, Scopus)
38. The clinical features and outcomes of Turkish patients with IgG4-related disease: a single-center experienceKARADAĞ Ö., Erden A., AYHAN E. A., BÖLEK E. Ç., KALYONCU U., ARMAĞAN B., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, sa.5, ss.1307-1314, 2017 (SCI-Expanded, Scopus, TRDizin)
39. Romatizmalı hastalar için bir yaşam kalitesi ölçeğiningeliştirilmesi: madde havuzunun oluşturulmasıÜNAL E., ARIN G., TÜRKMEN N. B., KİRAZ S., AKDOĞAN A., KALYONCU U., et al.Journal of Exercise Therapy and Rehabilitation, cilt.4, ss.62-75, 2017 (TRDizin)
40. Vaccination recommendations for adult patients with rheumatic diseases.DURUSU TANRIÖVER M., Akar S., Türkçapar N., KARADAĞ Ö., ERTENLİ A. İ., KİRAZ S.EUROPEAN JOURNAL OF RHEUMATOLOGY, cilt.3, sa.1, ss.29-35, 2016 (TRDizin)
41. Retro-orbital granuloma associated with granulomatosis with polyangiitis: a series of nine casesBitik B., KILIÇ L., Kucuksahin O., Sahin K., TUFAN A., KARADAĞ Ö., et al.RHEUMATOLOGY INTERNATIONAL, cilt.35, sa.6, ss.1083-1092, 2015 (SCI-Expanded, Scopus)
42. Levels of The Circulating Leukaemia Inhibitory Factor (LIF) in Patients with Vasculitis Under Immunosuppressive TherapyOzbalkan Z., KİRAZ S., ERTENLİ A. İ., Calguneri M.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)
43. MEFV mutation frequency and effect on disease severity in ankylosing spondylitisMaras Y., AKDOĞAN A., Kisacik B., KILIÇ L., YILMAZ E., TUFAN A., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.44, sa.2, ss.203-207, 2014 (SCI-Expanded, Scopus, TRDizin)
44. Successful treatment of primary Sjogren's syndrome complicated with primary biliary cirrhosis and lung involvementAltinbas A., Arik G., KALYONCU U., AKDOĞAN A., KARADAĞ Ö., Kisacik B., et al.TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.21, sa.1, ss.60-62, 2010 (SCI-Expanded, Scopus, TRDizin)
45. Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean feverKisacik B., AKDOĞAN A., Yilmaz G., KARADAĞ Ö., Yilmaz F. M., Koklu S., et al.EUROPEAN JOURNAL OF INTERNAL MEDICINE, cilt.20, sa.1, ss.44-47, 2009 (SCI-Expanded, Scopus)
46. Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean feverKİRAZ S., ERTENLİ A. İ., ARICI M., Calguneri M., HAZNEDAROĞLU İ. C., ÇELİK İ., et al.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.16, sa.6, ss.721-724, 1998 (SCI-Expanded, Scopus)

1. Psöriatik artrit hastalar›nda 5 yıllık anti-TNF alfa kullanımı sonrasında subklinik aterosklerozun değişimiERDEN A., CANPOLAT U., UYAROĞLU O. A., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.233-234, (Özet Bildiri)
2. COMPARISON OF SURVIVAL RATES AMONG SUBGROUPS OF PATIENTS EVALUATED FOR FEVER OF UNKNOWN ORIGINBİLGİN E., ARMAĞAN B., SARI A., BÖLEK E. Ç., Farisogullari B., YARDIMCI G. K., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.573, (Özet Bildiri)
3. UVEITIS RELATED FACTORS IN PATIENTS WITH SPONDYLOARTHRITISBilge N. S. Y., KAŞİFOĞLU T., KİRAZ S., ERTENLİ A. İ., Kucuksahin O., Dalkilic E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.491, (Özet Bildiri)
4. ANEURYSM IN BEHCET'S DISEASE: MANAGEMENT, PROGNOSIS AND MORTALITYARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.422, (Özet Bildiri)
5. SMOKING MAY BE RELATED TO SACROILIITIS IN ENTEROPATHIC ARTHRITIS PATIENTS: TREASURE REAL-LIFE PRELIMINARY DATAKucuksahin O., ERDEN A., Ilgen U., KİRAZ S., ERTENLİ A. İ., Bilge N. S. Y., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1824-1825, (Özet Bildiri)
6. CLINICAL FEATURES OF ANEURYSMAL BEHCET DISEASEARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1182, (Özet Bildiri)
7. ENTEROPATHIC ARTHRITIS PATIENTS UNDER BDMARD TREATMENTS HAD FREQUENTLY RADIOGRAPHIC SACROILIITIS: HUR-BIO REAL LIFE RESULTSYARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.478, (Özet Bildiri)
8. SKLERODERMA, SİSTEMİK LUPUS ERİTEMATOZUS VE FİBROMİYALJİ TANILI HASTALARIN HASTALIK HAKKINDAKİ BİLGİ DÜZEYLERİNİN İNCELENMESİARIN G., TÜRKMEN N. B., OFLAZ F. B., AKDOĞAN A., APRAŞ BİLGEN Ş. Ş., ERTENLİ A. İ., et al.3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, (Özet Bildiri)
9. Bağışıklık sistemi baskılanmış hastalarda Microsporidia ve fırsatçı bağırsak parazitlerinin varlığının araştırılmasıKaya F., İNKAYA A. Ç., AKSOY S., ABBASOĞLU O., ERTENLİ A. İ., BÜYÜKAŞIK Y., et al.4. Ulusal Klinik Mikrobiyoloji Kongresi, Türkiye, 8 - 12 Kasım 2017, (Özet Bildiri)
10. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life ResultsARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
11. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial SpondyloarthritisSARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
12. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish CohortsKARADAĞ Ö., ERDEN A., BİLGİNER Y., GOPALUNI S., SARI A., ARMAĞAN B., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
13. Sjögren Sendromu’nun Kas Güçsüzlüğü ile Prezantasyonu: Renal Tubuler Asidoz Tip 1BÖLEK E. Ç., ERDEN A., KOÇ H., KARADAĞ Ö., KALYONCU U., KİRAZ S., et al.19.Ulusal İç Hastalıkları Kongresi, Türkiye, 11 - 15 Ekim 2017, (Tam Metin Bildiri)
14. . IGG4-RELATED DISEASE IN EASTERN MEDITERRANEAN: CLINICAL FEATURES AND OUTCOMES OF A LARGE COHORTKARADAĞ Ö., ERDEN A., AYHAN E. A., BÖLEK E. Ç., ARMAĞAN B., KILIÇ L., et al.EULAR 2017, 6 - 10 Haziran 2017, cilt.76, ss.720, (Özet Bildiri)
15. Comorbidity and Surgery History of Rheumatoid Arthritis Patients Who Receiving Biological AgentARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.MIRCIM 2017 TIHUD-TIP JOINT MEETING, Krakow, Polonya, 11 - 14 Mayıs 2017, (Özet Bildiri)
16. SEROLOGICAL DETECTION OF STRONGYLOIDES STERCORALIS INFECTION IN IMMUNOSUPRESSED PATIENTS: HACETTEPE EXPERIENCEDEMİREL KAYA F., ERTENLİ A. İ., İNKAYA A. Ç., ABBASOĞLU O., AKSOY S., AKYÖN YILMAZ Y., et al.9TH BALKAN CONGRESS OF MICROBIOLOGY, SELANİK, Yunanistan, 22 - 24 Ekim 2015, (Özet Bildiri)
17. Serological Detection of Strongyloides strecoralis infection in immunosupressed patients Hacettepe ExperienceKaya F., ERTENLİ A. İ., İNKAYA A. Ç., ABBASOĞLU O., AKSOY S., AKYÖN YILMAZ Y., et al.Acta Microbiologica Helenica (9th Balkan Congress of Microbiology), 22 - 24 Ekim 2015
18. Anti TNF treatment may induce EBV reactivation in RA patients A clue for increased risk of lymphomaTOKGÖZOĞLU S. L., ERTENLİ A. İ., KALYONCU U., ALP A., KARADAĞ Ö., ERMAN M., et al.Annual European Congress of Rheumatology (EULAR 2006), 21 - 24 Haziran 2006, (Tam Metin Bildiri)
19. SAT0372 CHANGE OF SUBCLINICAL ATHEROSCLEROSIS AFTER FIVE YEARS ANTI-TNF TREATMENTS IN PSORIATIC ARTHRITISERDEN A., CANPOLAT U., UYAROĞLU O., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.
20. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life ResultsŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
21. Distribution of vasculitides in Eastern mediteranean: Results of a prospective cohortKARADAĞ Ö., ERDEN A., BATU E. D., BİLGİN E., UYAROGLU o., ŞEYHOĞLU E., et al.